FDA Inspection 1277363 — Human Genome Sciences Inc

Human Genome Sciences Inc — FEI 3003782237

The FDA completed an inspection of Human Genome Sciences Inc on July 31, 2025 in Rockville, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 31, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rockville, MD (United States)